SecBot SecBot

TNDM

TANDEM DIABETES CARE INC
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001438133 Healthcare & Medical Devices
$20.07 +2.56 (+14.62%)
Nov 13 4:00 PM ET · prev $17.51
Market cap
$1.2B
Small cap
Consensus
Buy
60% Buy or better · 30 analysts
Median target
$25.00
+25% · range $18.00–50.00
1 year
+9.4%
from $18.34 · Nov 17
30 days
+22.5%
from $16.38
52-week range
$12.82–28.26
−29% from high · low May 15
Avg volume 20D
2.73M
shares / day
Short interest
16.17M
≈23.2% of shares · +7.2%
Days to cover
7.6
at average volume
Insider net
−$32.6K
0 buyers · 1 seller · since May 20
New fund stakes
1
Q3 2026 13F · 1 exit
Filing reports
9
analyzed by SecBot
SecBot read BULLISH 6 reports · 90 days
Balance 1 bearish · 2 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 4/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $32.6K.

  • InstitutionsBULLISH

    Q3 2026: 23 added (1 new), 11 trimmed or exited.

  • AnalystsBULLISH

    18 of 30 rate it Buy or better. Median target $25.00 (+25%).

  • EstimatesFALLING

    Current-quarter EPS estimate $0.179 → $0.107 over 90 days. 0 up, 4 down in 30 days.

  • Short sellersSTEADY

    Short interest +7.2% to 16.17M shares. 7.6 days to cover, ≈23.2% of shares.

  • TrendUPTREND

    15% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 27.

Who's buying

13F· Q3 2026
1
new positions
1
exit
FundMoveSharesValue
UBS Group AGADD2,196,689$35.8M
BNP PARIBAS FINANCIAL MARKETSDOUBLED1,763,770$28.8M
FMR LLCADD1,328,828$21.7M
MORGAN STANLEYADD977,303$15.9M
Aberdeen Group plcTRIM121,948$14.0M
BANK OF MONTREAL /CAN/ADD736,172$12.0M
Qube Research & Technologies LtdTRIM427,115$7.0M
Jefferies Financial Group Inc.DOUBLED422,252$6.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

30 analysts
Buy 60% rate it Buy or better
Strong Buy7Buy11Hold12Sell0Strong Sell0
12-month targets · 21 analysts

Price is inside the target range. Median implies +25%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 6, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Nov 6, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Oct 7, 2026Barclays
INITIATE
INITIATEEqual-Weight
Sep 30, 2026Citigroup
MAINTAIN
MAINTAINNeutral
Sep 24, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Aug 21, 2026William Blair
INITIATE
INITIATEOutperform

Washington

Corporate Lobbying

9 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$32.6K
sold · 1 insider
DateInsiderTypeValue
Oct 27, 2026
TWOMEY CHRISTOPHER J
Director
Oct 27, 2026
EXERCISE$32.3K
Oct 27, 2026
TWOMEY CHRISTOPHER J
Director
Oct 27, 2026
SELL$32.6K
Oct 15, 2026
Kyrillos Jean-Claude
EVP & Chief Operating Officer
Oct 15, 2026
EXERCISE3,637 sh
Oct 15, 2026
Kyrillos Jean-Claude
EVP & Chief Operating Officer
Oct 15, 2026
TAX W/H$31.8K
Aug 15, 2026
Sheridan John F
PRESIDENT & CEO
Aug 15, 2026
TAX W/H$69.2K
Aug 15, 2026
Sheridan John F
PRESIDENT & CEO
Aug 15, 2026
EXERCISE9,934 sh
Aug 15, 2026
Sheridan John F
PRESIDENT & CEO
Aug 15, 2026
TAX W/H$114.8K
Aug 15, 2026
Sheridan John F
PRESIDENT & CEO
Aug 15, 2026
EXERCISE5,982 sh

Earnings setup

Estimates
$0.11
EPS estimate, this quarter
−40%
estimate change, 90 days
0↑ 4↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.11$0.01–$0.21-40.4%$291.5M
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY$0.10-$0.23–$0.57-40.1%$1.2B
Congressional trades
TNDM trades disclosed by members of Congress, with disclosure delay.
1 members · 2 buys / 0 sells
DateMemberType AmountDisclosed
Sep 29, 2026 Gilbert CisnerosDHouse Tandem Diabetes Care Inc BUY $1K–$15K Oct 12, 2026 +13d
Mar 3, 2026 Gilbert CisnerosDHouse Tandem Diabetes Care Inc BUY $1K–$15K Apr 7, 2026 +35d

Short side

FINRA· Oct 30, 2026
16,171,009
shares short
+7.2%
vs prior settlement
7.6
days to cover
≈23.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Tandem Diabetes Care received FDA 510(k) clearance for a tubeless cartridge and infusion set for its Tandem Mobi…
8-K · Impact 5/10
Nov 5, 2026 Earnings result
TNDM Q3 2026 Earnings: EPS $-0.1 (+59.5% vs est)
Oct 27, 2026 Insider
TWOMEY CHRISTOPHER J acquired via exercise 1,700 shares
Director @ $19.00 ($32.3K)
Oct 27, 2026 Insider
TWOMEY CHRISTOPHER J sold 1,700 shares
Director @ $19.15 ($32.6K)
Oct 15, 2026 Insider
Kyrillos Jean-Claude acquired via exercise 3,637 shares
EVP & Chief Operating Officer
Sep 30, 2026 Inst.
UBS Group AG · ADD
2,196,689 shares ($35.8M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 5, 2026
Earnings result
TNDM Q3 2026 Earnings: EPS $-0.1 (+59.5% vs est)
Aug 6, 2026
Earnings date
TNDM Q2 2026 Earnings After Market Close, 2026-08-06
May 7, 2026
Earnings date
TNDM Q1 2026 Earnings After Market Close, 2026-05-07
Mar 12, 2026
Short interest
FTD: TNDM, 28,127 shares ($0.6M) failed to deliver
Settlement: 20260312, Price: $22.16, FTD Value: $623,294.32, TANDEM DIABETES CARE INC COM N

SecBot reports

9 filings · 2 bullish · 1 bearish · 1 mixed · 5 neutral
All TNDM filing & press-release reports (9)